G.P.	Speaker/consultant fees from Abbott, Astra Zeneca, Sanofi, Amgen, Menarini, Bayer, Pfizer, BMS, Daiichi Sankyo, PIAM, Malesci, Sigma Tau, Chiesi, Medtronic, MSD, Boehringer Ingelheim. V.M.P., P.C., V.R., F.G., V.P., A.DO., and M.G.: nothing to disclose.
I.C.	Honoraria from BMS-Pfizer and Boehringer Ingelheim.
G.R.	Speaker/consultant fees from Astra Zeneca, Bayer, BMS-Pfizer, Boehringer Ingelheim, and Daiichi Sankyo.
R.D.C.	Co-author ESC Guidelines on Atrial Fibrillation 2010–2012; Steering Committee member, National Coordinator for Italy, and co-author of APPRAISE-2, ARISTOTLE, AVERROES, ENGAGE AF-TIMI 38, and Re-DUAL PCI; fees, honoraria and research funding from Sanofi-Aventis, Boehringer Ingelheim, Bayer, BMS/Pfizer, Daiichi-Sankyo, Novartis, Merck, Portola, Roche, AstraZeneca, Menarini, Guidotti, and Milestone.